abstract |
The invention relates to the use of substituted 4-amino-1-phenylbutan-2-ol compounds and their enantiomers, diastereomers, bases or salts of physiologically acceptable acids as regulators for the nociceptin / orphanin FQ ligand ORL1 receptor system and for the manufacture of drugs. |